Does TECLISTAMAB-CQYV Cause Plasma cell myeloma? 96 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Plasma cell myeloma have been filed in association with TECLISTAMAB-CQYV. This represents 6.0% of all adverse event reports for TECLISTAMAB-CQYV.
96
Reports of Plasma cell myeloma with TECLISTAMAB-CQYV
6.0%
of all TECLISTAMAB-CQYV reports
47
Deaths
22
Hospitalizations
How Dangerous Is Plasma cell myeloma From TECLISTAMAB-CQYV?
Of the 96 reports, 47 (49.0%) resulted in death, 22 (22.9%) required hospitalization, and 5 (5.2%) were considered life-threatening.
Is Plasma cell myeloma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
Pneumonia (58)
What Other Drugs Cause Plasma cell myeloma?
LENALIDOMIDE (14,191)
DEXAMETHASONE (9,207)
POMALIDOMIDE (7,023)
BORTEZOMIB (6,683)
IXAZOMIB (3,249)
DARATUMUMAB (2,980)
CARFILZOMIB (2,238)
CYCLOPHOSPHAMIDE (2,058)
THALIDOMIDE (1,652)
SELINEXOR (1,046)
Which TECLISTAMAB-CQYV Alternatives Have Lower Plasma cell myeloma Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL